Three years after the No Surprises Act (NSA) was enacted, industry stakeholders and government regulators alike are still navigating the intricate twists and turns of the wide-ranging legislation’s key provisions. In a new webinar, Manatt Health will explain the major developments impacting NSA and share critical insights into their implications for your organization. The CLE-eligible program will cover the full range of NSA issues and challenges, from court-mandated changes to the NSA’s Independent Dispute Resolution (IDR) process to the continuing flow of subregulatory guidance around Good Faith Estimates to the pending regulations still being written. Click here to register for the free webinar.
Key topics that will be covered include:
- An overview of the NSA
- An update on IDR litigation, including the Texas Medical Association decisions and their impact
- A review of the latest guidance on Good Faith Estimates
- A guide to understanding and overcoming NSA implementation challenges
- A look ahead to NSA developments to watch for in 2024
Even if you can’t attend our live session on March 7, click here to register for the free webinar now, and you’ll receive a link to view the program on demand.
Steven Chiu, Partner, Manatt Health
Harvey Rochman, Partner, Health Care Litigation
Marina Shvarts, Associate, Health Care Litigation
Date and Time
Thursday, March 7
1:00 – 2:00 p.m. ET
Click here to register for free.
CLE is pending in New York and California.
If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at firstname.lastname@example.org.
This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.